GPSM2 Rekombinanter Antikörper
GPSM2 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250793G2
Kat-Nr. : 86175-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86175-1-PBS bindet in WB, Indirect ELISA GPSM2 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | GPSM2 fusion protein Ag25195 |
| Vollständiger Name | G-protein signaling modulator 2 (AGS3-like, C. elegans) |
| Berechnetes Molekulargewicht | 75 kDa |
| Beobachtetes Molekulargewicht | 70-77 kDa |
| GenBank-Zugangsnummer | BC027732 |
| Gene symbol | GPSM2 |
| Gene ID (NCBI) | 29899 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
GPSM2 belongs to a family of proteins that modulate activation of G proteins. GPSM2 assists in the exchange of guanine nucleotides, and allows extracellular signals to be transmitted to cells via cell surface, and ultimately plays a key role in the activation of G-proteins. Therefore, GPSM2 is a critical factor for the stability of cell division. Some recent studies have shown that GPSM2 messenger RNA (mRNA) is overexpressed and plays a positive role in the development of certain tumors, such as liver cancer, pancreatic cancer, breast cancer. It also plays a role in neuroblast division and in the development of normal hearing. Mutations in GPSM2 are associated with autosomal recessive nonsyndromic deafness (DFNB82), which is a form of non-syndromic deafness characterized by prelingual, bilateral, severe, sensorineural hearing loss.



